PMID: 11321664Apr 26, 2001Paper

Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface area

Acta Oncologica
P PoikonenH Joensuu

Abstract

Chemotherapy doses are sometimes reduced because of obesity in patients. This study examines the effect of parameters reflecting the body size, body weight and height, body mass index (BMI), and body surface area (BSA) on the depth of the blood leukocyte nadir in breast cancer patients receiving adjuvant chemotherapy, when drug dosing was based on the BSA. Three hundred and forty patients with node positive breast cancer without distant metastases were treated with 6 cycles of adjuvant postoperative CMF (cyclophosphamide 600 mg/m2, methotrexate 40 mg/m2, and 5-fluorouracil 600 mg/m2 i.v. every 3 weeks). Patients within the highest BMI had the highest leukocyte nadir values (Spearman correlation coefficient 0.3, p < 0.001). A high body weight and a large BSA were also associated with high leukocyte nadirs. We conclude that when the blood leukocyte nadir is used as a surrogate marker for the drug effect, obese patients receiving intravenous CMF have higher leukocyte nadirs than the lean ones. Therefore, the drug doses should not be reduced because of obesity, and even when obese patients are treated according to the scheduled doses they may remain slightly underdosed.

References

Sep 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I F TannockH Sutherland
Jan 1, 1987·Cancer Chemotherapy and Pharmacology·G PowisJ N Ingle
Jan 1, 1985·Breast Cancer Research and Treatment·T EberleinM E Lippman
Mar 1, 1982·Clinical Pharmacokinetics·D R Abernethy, D J Greenblatt
Sep 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H Gurney
Nov 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G L RosnerR L Schilsky
Jul 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J Ratain
Jul 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H P GurneyG Farrell

❮ Previous
Next ❯

Citations

Oct 30, 2012·Bone Marrow Transplantation·B M WeissH M Lazarus
Jul 17, 2013·Nature Reviews. Clinical Oncology·Gary H Lyman, Alex Sparreboom
Jul 17, 2013·Nature Reviews. Clinical Oncology·Wenjing Tao, Jesper Lagergren
Aug 24, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K C HourdequinR J Larson
May 3, 2011·Journal of Oncology Practice·Monique D Lopes-SerraoSachin R Shah
Aug 22, 2007·Pediatric Hematology and Oncology·Carina RitzmoStaffan Eksborg
May 11, 2015·Gynecologic Oncology·Jean HansenMichael J Goodheart
Apr 15, 2015·Gynecologic Oncology·Neil S Horowitz, Alexi A Wright
Oct 17, 2008·Cancer Treatment Reviews·Rodney J HunterJudith A Smith
Dec 16, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Peter JenkinsSylvie Freeman
Sep 2, 2006·BJOG : an International Journal of Obstetrics and Gynaecology·A R Carmichael
Oct 14, 2006·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A R Carmichael
Aug 19, 2015·European Journal of Haematology·Martina CrysandtStefan Wilop
Sep 27, 2005·Lancet·Marco ColleoniUNKNOWN International Breast Cancer Study Group
Sep 12, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul K L ChinEvan J Begg
Apr 5, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer J GriggsUNKNOWN American Society of Clinical Oncology
Feb 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey A MeyerhardtCharles S Fuchs
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer J GriggsGary H Lyman
Aug 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Diana S M BuistRebecca A Silliman
Apr 29, 2014·International Journal of Clinical Pharmacy·Helena Anglada-MartínezNatàlia Creus-Baró
May 30, 2003·Bone Marrow Transplantation·W H Navarro
Dec 3, 2015·Clinical Medicine Insights. Oncology·Mohammed A Osman, Bryan T Hennessy
Nov 21, 2008·Cancer Chemotherapy and Pharmacology·Patrick A ThompsonStacey L Berg
Jul 22, 2005·Pediatric Blood & Cancer·Paul C RogersBeverly J Lange
Oct 24, 2002·Anti-cancer Drugs·E SalminenE Ekholm
Oct 9, 2003·Breast Cancer Research and Treatment·Jennifer J GriggsAndrew W Dick
Jun 12, 2021·Expert Review of Anticancer Therapy·Michelle ShayneGary H Lyman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.